Gaps in US Psychedelic Policy and How to Close Them
Caleigh Propes, Katherine Cheung, Matthew D. Eisenberg, David B. Yaden
原始摘要（英文原文）· Original abstract
This Viewpoint discusses how to fill policy gaps surrounding the use of psychedelics to treat mental health and substance use conditions, should they be approved by the US Food and Drug Administration.